Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeoGenomics

6.24
-0.4800-7.14%
Post-market: 6.260.0200+0.32%19:15 EDT
Volume:1.88M
Turnover:12.02M
Market Cap:803.05M
PE:-10.21
High:6.79
Open:6.75
Low:6.22
Close:6.72
Loading ...

NeoGenomics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
27 Feb

NeoGenomics price target lowered to $18 from $21 at Piper Sandler

TIPRANKS
·
26 Feb

NeoGenomics to Participate in Upcoming Investor Conferences

Business Wire
·
24 Feb

NeoGenomics: Strong Core Business and Growth Catalysts Justify Buy Rating Despite Challenges

TIPRANKS
·
20 Feb

NeoGenomics price target lowered to $17 from $18 at BTIG

TIPRANKS
·
20 Feb

Stock Track | NeoGenomics Stock Soars 5.2% on Strong Q4 Revenue and Clinical Growth

Stock Track
·
20 Feb

NeoGenomics price target lowered to $19 from $20 at TD Cowen

TIPRANKS
·
19 Feb

NeoGenomics price target lowered to $16 from $19 at BofA

TIPRANKS
·
19 Feb

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), NeoGenomics (NEO) and Medtronic (MDT)

TIPRANKS
·
19 Feb

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
19 Feb

Neogenomics Inc : Bofa Global Research Cuts Price Objective to $16 From $19

THOMSON REUTERS
·
19 Feb

NeoGenomics Is Maintained at Buy by Needham

Dow Jones
·
19 Feb

U.S. RESEARCH ROUNDUP-Axsome Therapeutics, Penumbra, Republic Services

Reuters
·
19 Feb

NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com
·
19 Feb

Neogenomics Inc : Jefferies Cuts Target Price to $18 From $22

THOMSON REUTERS
·
19 Feb

Q4 2024 Neogenomics Inc Earnings Call

Thomson Reuters StreetEvents
·
19 Feb

NeoGenomics Achieves Double-Digit Revenue Growth in 2024

TIPRANKS
·
19 Feb

NeoGenomics Q4 Earnings Call Highlights Growth Amid Challenges

TIPRANKS
·
19 Feb

NeoGenomics: Overcoming Short-term Setbacks with Strategic Growth Initiatives and Leadership Transition

TIPRANKS
·
19 Feb

NeoGenomics Shares Decline on Forecast for Wider-Than-Expected Loss in 2025

Dow Jones
·
19 Feb